19 November 2015
DETAILS
The Chemours Company (“Chemours”) (NYSE: CC),
a global chemical company with leading market positions in
titanium technologies, fluoroproducts and chemical solutions,
has signed a definitive agreement
to sell its aniline facility in Beaumont, Texas
to The Dow Chemical Company (Dow)
for approximately $140 million in cash.
The transaction close is subject to customary approvals
and closing conditions.
As part of this transaction, Chemours has entered into
an agreement to meet Dow’s additional aniline requirements
with supply from its Pascagoula, Mississippi facility.
Chemours will continue to serve other aniline customers
from its Pascagoula plant.
Chemours president and CEO
“We have moved rapidly since Chemours was created in July
to capture
substantial cost reductions and streamline our portfolio,”
“We will continue to take actions to deliver on
every aspect of our five-point transformation plan, and
to enable greater focus on our businesses
that have the strongest advantages and
greatest market opportunities.”
“Dow owning the Beaumont aniline facility is a natural fit,
since Dow has been our largest aniline customer
for many years.
Our aniline facility employees have been
a valued part of our company, and we wish
them well in this next chapter of their working lives.”
WWW.CHEMWINFO.COM BY KHUN PHICHAI
